The following article requires a subscription:

(Format: HTML, PDF)

Purpose. To report a case of erosive conjunctivitis and punctal stenosis occurring secondarily in a patient who underwent administration of docetaxel.

Methods. Observational case report: a 58-year-old female with metastatic breast cancer developed erosive conjunctivitis and punctal stenosis after undergoing administration of systemic docetaxel.

Results. Resolution of the erosive conjunctivitis occurred after discontinuation of docetaxel. The punctal stenosis persisted.

Conclusion. Patients receiving treatment with docetaxel require frequent monitoring to discover potentially irreversible ocular damage.

(C) 2003 Lippincott Williams & Wilkins, Inc.